Month: May 2023

Four hospital systems had accused the state of Oregon of forcing them to warehouse patients, in violation of their civil rights. Click here to view original post

The Bothell-based company is developing a plant-based smoking cessation treatment. Click here to view original post

Seal Rock eligible to receive payments up to €100 million, including regulatory, clinical, and commercial milestone payments, plus tiered royalties SEATTLE, May 31, 2023 /PRNewswire/ — Seal Rock Therapeutics, Inc., a clinical stage company developing […]

Nurses spent months hammering out a safe staffing bill with the hospital association. Click here to view original post

SEATTLE–(BUSINESS WIRE)–Zap Energy was selected for support of the design of a fusion pilot plant through the U.S. Milestone-Based Fusion Development Program. Click here to view original post

Redmond-based startup Cadence Neuroscience raised $26 million in a Series B funding round that will be used toward finishing clinical studies and working on receiving clearance from the Food and Drug Administration (FDA). Cadence Neuroscience […]

One of Company’s largest destinations spanning more than 235,000 square feet marks 30th state of operation and creates nearly 300 new jobs in Beaverton BEAVERTON, Ore., May 31, 2023 /PRNewswire/ — Life Time (NYSE: LTH), […]

Milliman recognized in PLANSPONSOR’s 2022 Defined Contribution Survey SEATTLE, May 31, 2023 /PRNewswire/ — Milliman, Inc., one of the premier actuarial, consulting, and benefits administration firms, is pleased to announce that it has been recognized […]

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will […]

SEATTLE, May 30, 2023 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) (“CTI”), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that it has cancelled […]